|
시장보고서
상품코드
2054299
수의 피부과용 의약품 시장 : 약제 유형별, 대상 동물별, 지역별Veterinary Dermatology Drugs Market, By Type of Drug, By Animal Type, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
수의 피부과용 의약품 시장은 2026년에 32억 8,000만 달러로 추계되고 있으며, 2033년까지 55억 7,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 7.9%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모 : 2026년 | 32억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR : 2026-2033년 | 7.90% | 시장 규모 예측 : 2033년 | 55억 7,000만 달러 |
수의 피부과용 의약품은 동물의 피부 질환 치료에 사용되는 치료제입니다. 이 의약품들은 피부암, 세균 감염증, 기생충 감염의 치료를 목적으로 개발되었습니다. 수의 의료 서비스의 고도화로 인해, 수의사는 다양한 만성 질환 및 감염증에 대해 폭넓은 치료 옵션을 제공할 수 있게 되었습니다. 이러한 기술 덕분에 수의사와 반려인 모두에게 수의 의료 서비스가 더욱 편리하고 비용 대비 효과가 높은 것으로 자리 잡았습니다.
시장 역학
반려동물 주인들 사이에서 동물 건강에 대한 관심이 높아짐에 따라, 수의 피부과용 의약품 시장은 앞으로 큰 성장이 예상됩니다. 또한, 기생충 서식 환경의 생태계 변화, 기후 변화, 매개체와 숙주 간의 상호작용 증가, 풍토병 지역으로의 외래종 유입, 그리고 기존 풍토병 지역 밖에서 매개체에 의한 감염병 발생 위험이 높아지는 점 역시 전 세계 수의학 피부과용 의약품 시장의 성장을 견인할 것으로 예측됩니다. 또한, 더욱 발전된 분자진단 및 치료 기술의 진보 역시 수의 피부과용 의약품 시장의 성장을 더욱 촉진할 것으로 전망됩니다.
반면, 엄격한 승인 규제와 약물에 따른 부작용이 시장 성장을 저해할 것으로 예측됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략)를 바탕으로 전 세계 수의학 피부과용 의약품 시장의 주요 기업들을 분석했습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 수의 피부과용 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 수의학 피부과 의약품 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 수의 피부과용 의약품 시장 : 약제 유형별(2021-2033년)
제5장 세계의 수의 피부과용 의약품 시장 : 동물 유형별(2021-2033년)
제6장 세계의 수의 피부과용 의약품 시장 : 지역별(2021-2033년)
제7장 경쟁 구도
제8장 섹션
AJY 26.06.17Veterinary Dermatology Drugs Market is estimated to be valued at USD 3.28 Bn in 2026 and is expected to reach USD 5.57 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.28 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.90% | 2033 Value Projection: | USD 5.57 Bn |
Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.
Market Dynamics
The veterinary dermatology drugs market is expected to witness significant growth in the future due to the rising awareness about animal health among pet owners. Additionally, changes in the ecology of parasite habitat, climate change, increase in vector-host interactions, the introduction of foreign species in endemic areas, and high risk of vector-borne infection outside traditional endemic areas are also expected to drive the global veterinary dermatology drugs market growth. Moreover, advancements in technology for better molecular diagnostics and treatments are further anticipated to propel veterinary dermatology drug market growth.
On the contrary, strict approval regulations and side effects associated with the drugs are expected to restrict market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global veterinary dermatology drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global veterinary dermatology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary dermatology drugs market.
Market Segmentation
- Global Veterinary Dermatology Drugs Market, By Type of Drug (Revenue, USD Bn, 2021 - 2033)
- Antibiotics
- Antifungal drugs
- Anti-inflammatory drugs
- Immunotherapy drugs
- Parasiticides
- Others
- Global Veterinary Dermatology Drugs Market, By Animal Type (Revenue, USD Bn, 2021 - 2033)
- Dogs
- Cats
- Horses
- Others
- Global Veterinary Dermatology Drugs Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Boehringer Ingelheim International GmbH
- Virbac
- Vetoquinol S.A.
- Dechra Pharmaceuticals PLC
- Bayer AG
- Ceva Sante Animale
- Kindred Biosciences, Inc.
- IDEXX Laboratories, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type of Drug
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Growing prevalence of skin disease in animals
- Rise in number of pet owners
- Restraints
- Lack of awareness across developing countries
- Side-effects associated with drugs
- Strict approval regulations
- Opportunities
- Increasing investment by government and private sectors
- Development of cutting-edge therapies
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Veterinary Dermatology Drugs Market , By Type of Drug, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Antifungal drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Anti-inflammatory drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Immunotherapy drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Parasiticides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
5. Global Veterinary Dermatology Drugs Market , By Animal Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)
- Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)
- Horses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Billion)
6. Global Veterinary Dermatology Drugs Market , By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2021 - 2033,(USD Bn)
- GCC Countries
- Israel
- South Africa
- North Africa
- Central Africa
7. Competitive Landscape
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vetoquinol S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Dechra Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kindred Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IDEXX Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
8. Section
- Research Methodology
- About us
